Osaka, Japan

Hiroyasu Ogawa

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyasu Ogawa. Retrieved from https://idiyas.com/inventor/hiroyasu-ogawa-cec9dk62

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroyasu Ogawa: Innovator in Eukaryotic Expression Systems

Introduction

Hiroyasu Ogawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of eukaryotic expression systems. His work has implications for gene cloning and the study of gene expression in response to drug treatment.

Latest Patents

Hiroyasu Ogawa holds 1 patent for his invention titled "Eukaryotic expression vector system." This patent relates to two plasmid vectors and the eukaryotic expression vector created from them. The invention also includes methods for cloning genes in eukaryotic cells, constructing subtracted cDNA libraries, and identifying eukaryotic genes that inhibit cell growth.

Career Highlights

Ogawa is currently associated with the United States of America as represented by the Department of Health. His work in this capacity has allowed him to collaborate on various projects that advance the understanding of gene expression and its applications in medicine.

Collaborations

Some of his notable coworkers include Chandrakant P Giri and Curtis C Harris. Their collaborative efforts have contributed to the success of various research initiatives in the field of biotechnology.

Conclusion

Hiroyasu Ogawa's innovative work in eukaryotic expression systems showcases his commitment to advancing biotechnology. His contributions are vital for future research and applications in gene therapy and drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…